Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-21
    E.g., 2018-10-21

Archive Search

2 results
12:00 AM, Sep 07, 2015  |  BC Week In Review | Company News  |  Deals

Mabtech, Sorrento deal

Mabtech granted Sorrento exclusive rights to develop and commercialize four undisclosed biosimilar mAbs in North America …
and that two are under review in China. Sorrento did not respond to inquiries, and Mabtech
could not be reached. Mabtech Ltd. ,   Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif.   …
12:00 AM, Mar 18, 2002  |  BC Week In Review | Company News  |  Deals

Seattle Genetics, Mabtech AB deal

Mabtech granted SGEN an exclusive license to certain monoclonal antibodies that target cell surface molecules on …
with its antibody-drug conjugate (ADC) technology. Under a 1998 deal, SGEN licensed rights to a Mabtech
expect to start clinical testing later this year. Seattle Genetics Inc. (SGEN), Bothell, Wash.   Mabtech